Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (26)
2023
-
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Respiratory Research, Vol. 24, Núm. 1
-
Altered insulin secretion dynamics relate to oxidative stress and inflammasome activation in children with obesity and insulin resistance
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
Acta Dermato-Venereologica, Vol. 103
-
Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort
Antibiotics, Vol. 12, Núm. 1
-
Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation
Intensive Care Medicine
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
Journal of Investigational Allergology and Clinical Immunology
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
2022
-
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
The Lancet Regional Health - Europe, Vol. 18
-
Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort
Antibiotics, Vol. 11, Núm. 6
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
2021
-
Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study)
International Journal of Antimicrobial Agents, Vol. 58, Núm. 1
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
2016
-
Omalizumab: What benefits should we expect?
European Journal of Dermatology, Vol. 26, Núm. 4, pp. 340-344
-
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients
Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152
2014
2012
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7